Editor's Note: CIDRAP's Public Health Practices online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.
(CIDRAP News) An H5N1 influenza vaccine based on a weakened adenovirus was tested successfully in mice and may offer advantages as a tool for combating a human flu pandemic, according to researchers from the Centers for Disease Control and Prevention (CDC) and Purdue University.
(CIDRAP News) The US Department of Health and Human Services (HHS) yesterday held a live Web seminar (webinar) to provide guidance on and field questions about school closures as a social distancing tool that could be used in an influenza pandemic.
(CIDRAP News) – The US Department of Health and Human Services (HHS) has accepted the first batch of H5N1 avian influenza vaccine based on the H5N1 variant known as clade 2.2, which has spread most widely across Asia, Europe, and Africa.
(CIDRAP News) The US government will need to expand its stockpile of antiviral drugs if the goal is to have enough doses to treat all patients and provide preventive treatment for some others at risk in an influenza pandemic, the Institute of Medicine (IOM) says in a report issued today.
(CIDRAP News) An Indonesian health official, responding to recent comments by the US health secretary, today denied that Indonesia wants financial compensation if it resumes sharing its H5N1 avian influenza virus samples.
(CIDRAP News) – Acting on the premise that "disasters discriminate," the Association of State and Territorial Health Officials (ASTHO) and several partner groups yesterday released a lengthy set of proposed guidelines for protecting the most vulnerable people during an influenza pandemic.
(CIDRAP News) Japan's health ministry today said it was on the verge of approving a plan to administer prepandemic vaccine to healthcare workers, which would make it the world's first country to tap its national stockpile for this purpose.
(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.
(CIDRAP News) Recent pandemic influenza response exercises have helped the Centers for Disease Control and Prevention (CDC) improve its tools for making policy decisions quickly, according to senior CDC officials.
